ConsumerLab.com uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.

About ConsumerLab.com

Posted January 2, 2012

FDA Warns XYMOGEN of Manufacturing and Labeling Violations Regarding Multiple Products

On December 13, 2011, the U.S. FDA sent a Warning Letter to Atlantic Pro Nutrients, Inc. (dba XYMOGEN) regarding labeling and/or manufacturing violations relating to its products, which include Borage CP-240, CoQmax CF, Immune Rx, Iron Glycinate, and Green Tea 600. For details, see the Warning Letter using the link below.